Advertisement
Screener

Savara Inc (SVRA) Investment Income, Interest

2.2 / 5 stars · 17/39 Roast Me

Savara Inc Investment Income, Interest

Savara Inc (SVRA) reported Investment Income, Interest of $11.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.

Discontinued › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2017-05-09

  • Savara Inc investment income, interest for the quarter ending 2017-03-31 was $11.00K, a 71.79% decline year-over-year.
  • Savara Inc investment income, interest for the quarter ending 2016-12-31 was $15.00K, a 58.33% decline year-over-year.
  • Savara Inc investment income, interest for the quarter ending 2016-09-30 was $31.00K, a 3.13% decline year-over-year.
  • Savara Inc investment income, interest for the quarter ending 2016-06-30 was $36.00K, a 12.50% increase year-over-year.
  • Savara Inc investment income, interest for fiscal 2016 was $122.00K, a 6.15% decline from fiscal 2015.
  • Savara Inc investment income, interest for fiscal 2015 was $130.00K, a 88.41% increase from fiscal 2014.
  • Savara Inc investment income, interest for fiscal 2014 was $69.00K, a 15.00% increase from fiscal 2013.
  • Savara Inc investment income, interest for fiscal 2013 was $60.00K, a 18.43% decline from fiscal 2012.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 3 month as first filedInvestment Income, Interest 6 monthInvestment Income, Interest 6 month as first filedInvestment Income, Interest 9 monthInvestment Income, Interest 9 month as first filedInvestment Income, Interest 12 monthInvestment Income, Interest 12 month as first filedInvestment Income, Interest 181 monthInvestment Income, Interest 184 monthInvestment Income, Interest 187 monthInvestment Income, Interest 190 monthInvestment Income, Interest 193 monthInvestment Income, Interest 196 monthInvestment Income, Interest 199 monthInvestment Income, Interest 202 monthInvestment Income, Interest 205 monthInvestment Income, Interest 208 monthInvestment Income, Interest 211 monthInvestment Income, Interest 214 month
2017-03-31$11.00K
10-Q · filed 2017-05-09
$26.00K
derived: sum of 2 quarters · filed 2017-05-09
$57.00K
derived: sum of 3 quarters · filed 2017-05-09
$93.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$46.00K
derived: sum of 2 quarters · filed 2017-03-06
$82.00K
derived: sum of 3 quarters · filed 2017-03-06
$122.00K
10-K · filed 2017-03-06
2016-09-30$31.00K
10-Q · filed 2016-11-08
$67.00K
derived: sum of 2 quarters · filed 2016-11-08
$107.00K
10-Q · filed 2016-11-08
$142.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-06-30$36.00K
10-Q · filed 2016-08-09
$75.00K
10-Q · filed 2016-08-09
$111.00K
derived: sum of 3 quarters · filed 2017-05-09
$143.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-03-31$39.00K
10-Q · filed 2017-05-09
$75.00K
derived: sum of 2 quarters · filed 2017-05-09
$107.00K
derived: sum of 3 quarters · filed 2017-05-09
$139.00K
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$68.00K
derived: sum of 2 quarters · filed 2017-03-06
$100.00K
derived: sum of 3 quarters · filed 2017-03-06
$130.00K
10-K · filed 2017-03-06
2015-09-30$32.00K
10-Q · filed 2016-11-08
$64.00K
derived: sum of 2 quarters · filed 2016-11-08
$94.00K
10-Q · filed 2016-11-08
$113.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$32.00K
10-Q · filed 2016-08-09
$62.00K
10-Q · filed 2016-08-09
$81.00K
derived: sum of 3 quarters · filed 2017-03-06
$99.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$30.00K
10-Q · filed 2016-05-06
$49.00K
derived: sum of 2 quarters · filed 2017-03-06
$67.00K
derived: sum of 3 quarters · filed 2017-03-06
$84.00K
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$37.00K
derived: sum of 2 quarters · filed 2017-03-06
$54.00K
derived: sum of 3 quarters · filed 2017-03-06
$69.00K
10-K · filed 2017-03-06
2014-09-30$18.00K
10-Q · filed 2015-11-12
$17.38K
10-Q · filed 2014-10-31
$35.00K
derived: sum of 2 quarters · filed 2015-11-12
$50.00K
10-Q · filed 2015-11-12
$49.59K
10-Q · filed 2014-10-31
$67.36K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$17.00K
10-Q · filed 2015-08-12
$16.87K
10-Q · filed 2014-08-11
$32.00K
10-Q · filed 2015-08-12
$32.22K
10-Q · filed 2014-08-11
$49.36K
derived: sum of 3 quarters · filed 2015-08-12
$66.69K
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$15.00K
10-Q · filed 2015-05-11
$15.35K
10-Q · filed 2014-05-05
$32.36K
derived: sum of 2 quarters · filed 2015-05-11
$49.69K
derived: sum of 3 quarters · filed 2015-05-11
$60.58K
derived: sum of 4 quarters · filed 2015-05-11
$4.91M
10-Q · filed 2014-05-05
2013-12-31$17.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24
$34.69K
derived: sum of 2 quarters · filed 2015-03-24
$45.58K
derived: sum of 3 quarters · filed 2015-03-24
$60.00K
10-K · filed 2015-03-24
$60.27K
10-K · filed 2014-03-26
$4.89M
10-K · filed 2014-03-26
2013-09-30$17.33K
10-Q · filed 2014-10-31
$28.22K
derived: sum of 2 quarters · filed 2014-10-31
$42.64K
10-Q · filed 2014-10-31
$59.90K
derived: sum of 4 quarters · filed 2014-10-31
$4.87M
10-Q · filed 2013-11-04
2013-06-30$10.89K
10-Q · filed 2014-08-11
$25.31K
10-Q · filed 2014-08-11
$42.57K
derived: sum of 3 quarters · filed 2014-08-11
$60.92K
derived: sum of 4 quarters · filed 2014-08-11
$4.86M
10-Q · filed 2013-08-05
2013-03-31$14.42K
10-Q · filed 2014-05-05
$31.68K
derived: sum of 2 quarters · filed 2014-05-05
$50.02K
derived: sum of 3 quarters · filed 2014-05-05
$69.31K
derived: sum of 4 quarters · filed 2014-05-05
$4.85M
10-Q · filed 2013-05-15
2012-12-31$17.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
$35.61K
derived: sum of 2 quarters · filed 2014-03-26
$54.89K
derived: sum of 3 quarters · filed 2014-03-26
$73.56K
10-K · filed 2014-03-26
$4.83M
10-K · filed 2013-03-19
2012-09-30$18.35K
10-Q · filed 2013-11-04
$37.63K
derived: sum of 2 quarters · filed 2013-11-04
$56.30K
10-Q · filed 2013-11-04
$70.67K
derived: sum of 4 quarters · filed 2013-11-04
$4.81M
10-Q · filed 2012-11-05
2012-06-30$19.29K
10-Q · filed 2013-08-05
$37.95K
10-Q · filed 2013-08-05
$52.32K
derived: sum of 3 quarters · filed 2013-08-05
$59.66K
derived: sum of 4 quarters · filed 2013-08-05
$4.80M
10-Q · filed 2012-08-06
2012-03-31$18.67K
10-Q · filed 2013-05-15
$29.38K
10-Q · filed 2012-05-07
$33.03K
derived: sum of 2 quarters · filed 2013-05-15
$40.38K
derived: sum of 3 quarters · filed 2013-05-15
$51.37K
derived: sum of 4 quarters · filed 2013-05-15
$4.79M
10-Q · filed 2012-05-07
2011-12-31$14.37K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19
$21.71K
derived: sum of 2 quarters · filed 2013-03-19
$32.71K
derived: sum of 3 quarters · filed 2013-03-19
$65.58K
10-K · filed 2013-03-19
$76.59K
10-K · filed 2012-03-08
$4.76M
10-K · filed 2012-03-08
2011-09-30$7.34K
10-Q · filed 2012-11-05
$18.34K
derived: sum of 2 quarters · filed 2012-11-05
$51.21K
10-Q · filed 2012-11-05
$76.08K
derived: sum of 4 quarters · filed 2012-11-05
$4.73M
10-Q · filed 2011-11-08
2011-06-30$11.00K
10-Q · filed 2012-08-06
$43.87K
10-Q · filed 2012-08-06
$68.74K
derived: sum of 3 quarters · filed 2012-08-06
$94.99K
derived: sum of 4 quarters · filed 2012-08-06
$4.73M
10-Q · filed 2011-08-08
2011-03-31$32.87K
10-Q · filed 2012-05-07
$57.74K
derived: sum of 2 quarters · filed 2012-05-07
$84.00K
derived: sum of 3 quarters · filed 2012-05-07
$107.30K
derived: sum of 4 quarters · filed 2012-05-07
2010-12-31$24.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08
$51.13K
derived: sum of 2 quarters · filed 2012-03-08
$74.43K
derived: sum of 3 quarters · filed 2012-03-08
$92.87K
10-K · filed 2012-03-08
2010-09-30$26.26K
10-Q · filed 2011-11-08
$49.57K
derived: sum of 2 quarters · filed 2011-11-08
$68.01K
10-Q · filed 2011-11-08
2010-06-30$23.31K
10-Q · filed 2011-08-08
$41.75K
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B